FDA Investigator Sarah E Rhoades

Sarah E Rhoades has inspections in 3 countries as of 20 Oct 2023. Sarah E Rhoades has collaborated with a combinined 4783 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
37
Last Inspection Date:
20 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Japan, Canada
Co-Investigator(s):
Aditi S Thakur, Adree N Anderson, Alan M Barker, Alan P Kurtzberg, Alanna Lmussawwir Bias, Alexandra A Carrico, Alice S Tsao, Amanda S Zorn, Amy S Graf, Ana Paulap Sandee, Anders W Evenson, Andrew A Hoopes, Andrew J Barrowcliff, Anthony F Lorenzo, Anthony R Bucks, Arsen Karapetyan, Art O Czabaniuk, Ashley A Mutawakkil, Ava M Bowman, Azza Talaat, Barbara Janine Breithaupt, Bei Y He, Brentley S Collins, Brett R Havranek, Brian D Nicholson, Brittany A Mckenzie, Brittany D Terhar, Carl A Huffman, III, Carla J Lundi, Caroline H Le, Carrie Ann Plucinski, Catherine V Quinlan, Cathie S Marshall, CDR Ileana Barreto Pettit, Charles I Ann, Charles R Cote, RIC, Christian D Lynch (CDL), Christine A Harman, PhD, Christine J Watts, Christopher D Leach, Christopher T Middendorf, Cody D Rickman, Constantin Y Philopoulos, Courtney E Hillier, Crystal L Parks, Damaris Y Hernandez, Danial S Hutchison, Daniel J Brown, Daniel J Gorski, Daniel L Obrzut, Danielle S Mills, Darren S Morgan, David J Eide, David J Gasparovich, David L Wilson, David P Moorhead, David Perkins, Dawn C Olenjack, Deborah J Parris, Deborah M Trout, Debra I Love, Denise L Burosh, Donald L Myers, Eileen A Liu, Eliezar Ramos, Elizabeth Ll Edwards, Emilie E Kahn, Emilie E, Kahn, Emily J Orban, Eric M Mueller, PharmD, Eric M Padgett, Eric S Weilage, Erika V Butler, French, Gene D Arcy, Geneve M Maxwell, Geneve M Parks, Geneve Maxwell, Gilbert J Heidenblut, Gwyn G Dickinson, Hartman, Hassan M Fakhreddine, Hector A Carrero, Helen B Ricalde, Helen Y Saccone, Himanshu Gupta, PhD, Hokenson, Hugh M Mcclure, II, Jacob G Lutz, Jacob W Reynolds, Jacqueline Mdiaz Albertine, Jacqueline Mdiaz Albertini, James I Giefer, James K Ireland, James R Evans, James W Plucinski, Janet B Abt, Janet L Bowen, Jasjeet K Sekhon, Jason F Chancey, Jazmine N Still, Jefferey A Hangartner, Jeffery A Hangartner, Jeffrey A Sincek, Jeffrey A Sommers, Jeffrey D Meng, Jmaes I Giefer, John N Woodall, Jonathan R Campos, Joohi Castelvetere, Joseph A Piechocki, Joseph R Lambert, Joseph T Madak, Joshua P Wireman, Juanita P Versace, Justin A Boyd, Karen C Daugherty, Karen E D'orazio, Kathryn A Guardiola, Kathryn G Brown, Kelly K Nachtigal, Ken L Bowers, Kenneth E Felkley, Kevin D Kallander, Kristina Nastovski, Larry K Austin, Laureen F Kononen, Laurel A Beer, Lauren E Sexton, Lauren M Lilly, PhD, Laurie A Haxel, Leon R Marquart, Lequita M Mayhew, Leslie A Paul, Linda F Murphy, Linda S Jozefiak, Lindsey Brown, PhD, Lindsey M Schwierjohann, Lisa C Lewis, Lisa J Joseph, Lisa P Oakes, LT Tamara J Henderson, Makini Cobourne Duval, PhD, Margaret A Smithers, Marion Michaelis, Marlon K Turner, Martha Sullivan Myrick, Martin R Vowell, Matthew B Casale, Matthew J Gretkierewicz, Matthew M Schuckmann, Matthew R Sleeter, Miah I Schneider, Michael E Maselli, Michael K Larson, Michael Shanks, MS, Michael Y Philopoulos, Michele L Forster, PhD, Michele L Glendenning, Michele L Obert, Michele Perry Williams, Michelle L Jones, Mihaly S Ligmond, Mikhail V Ovanesov, PhD, Mohsen Rajabi Abhari, FDA, Monica M Mcclure, Myra K Casey, Nancy G Schmidt, Nibin Varghese, MS, Nicholas E Boyd, Nicholas F Lyons, Nicholas J Presto, Nicholas L Paulin, Nicholas Z Lu, Noreen Muniz, Omotunde O Osunsanmi, Owens, Paraluman S Leonin, Patrick L Wisor, Patsy I Domingo, Patsy J Domingo, Paula A Trost, Philip A Klimkewicz, Phillip M Pontikos, Phung Thien Nguyen, Prabhu P Raju, Ralph A Erickson, Ralph H Vocque, Rasha Bamieh, Raymond R Roy, PhD, Raymond T Oji, Rebecca E Dombrowski, Richard L Rutherford, Rita K Kabaso, Robert C Coleman, Robert D Tollefsen, Robert J Ham, Robert M Barbosa, Robert P Whisenant, Robert R Barbosa, Robert Rodriguez, Rochelle K Kimmel, Roger A Hartman, Roger F Zabinski, Rohn R Robertson, Ronald G Crawford, Rose M Ashley, Roshni J Patel, Russell K Riley, Ryan J Benedict, Salwa K Poole, Samuel T Walker, Sandra A Boyd, Sandra A Hughes, Sanket N Patel, Sarah E Mcmullen, Sarah M Meng, Sarah M Napier, Satheesh Thomas, Schwierjohann Schwierjohann, Lindsey, Scott A Golladay, Scott B Laufenberg, Shafiq S Ahadi, Sharon K Thoma, PharmD, Sherri L Clark, Shirley J Berryman, Shirshendu K Deb, PhD, Sidney B Priesmeyer, Simone E Pitts, State Agency, Steven D Kehoe, Steven E Bowen, PhD, Steven Fong, MS, PhD, Steven P Donald, Steven Wienman, Susan M Jackson, Susan P Bruederle, Susanna E Ford, Analyst, Suyang Qin, Tara L Breckenridge, Tara L Greene, Thomas A Peter, Thomas J Cosgrove, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Tina M Pawlowski, Tina S Roecklein, Todd M Stankewicz, Tonnie L Carter, Torrey M Ward, Tracey Asinjen Wiersma, Twana R Chandler, Victoria A Murray, Walsworth, Walsworth Walsworth, Wayne D Mcgrath, Wendy M Stark, William D Tingley, William G Craig, William G Nelson, William R Brubaker, Yvonne E Lozano, Zi Qiang Gu

Sarah E Rhoades's Documents

Publish Date Document Type Title
January, 2018 EIR Future Pak LLC - EIR, 2018-01-11
September, 2019 EIR SpecGx LLC - EIR, 2019-09-12
December, 2018 EIR LEXAMED - EIR, 2018-12-06
April, 2017 EIR Coram Healthcare Corp. of Indiana - EIR, 2017-04-26
August, 2016 EIR Par Sterile Products LLC - EIR, 2016-08-26
April, 2019 FDA 483 Response Par Sterile Products LLC - Form 483R, 2019-05-02
December, 2019 FDA 483 Future Pak LLC - Form 483, 2019-12-12
December, 2018 FDA 483 LEXAMED - Form 483, 2018-12-06
June, 2019 FDA 483 RXQ Compounding LLC - Form 483, 2019-06-06
February, 2017 FDA 483 pharMerica - Form 483, 2017-02-23
April, 2017 FDA 483 Coram Healthcare Corp. of Indiana - Form 483, 2017-04-26
April, 2017 FDA 483 Response Coram Healthcare Corp. of Indiana - Form 483R, 2017-05-31
December, 2017 FDA 483 AMERICAN PHARMACEUTICAL INGREDIENTS LLC d.b.a American Pharmaceutical Distributors - Form 483, 2017-12-14
September, 2019 FDA 483 Response SpecGx LLC - Form 483R, 2019-09-27
April, 2019 EIR Par Sterile Products LLC - EIR, 2019-04-15
October, 2017 EIR Hospira, Inc. - EIR, 2017-10-27
July, 2019 FDA 483 TOYOBO CO., LTD. - Form 483, 2019-07-30
April, 2019 FDA 483 Par Sterile Products LLC - Form 483, 2019-04-15
October, 2019 FDA 483 LEXAMED - Form 483, 2019-10-10
November, 2018 FDA 483 Ecolab Inc. - Form 483, 2018-11-09
October, 2017 FDA 483 Hospira, Inc. - Form 483, 2017-10-27
August, 2016 FDA 483 Par Sterile Products LLC - Form 483, 2016-08-26
September, 2019 EIR PPD Development, L.P. - EIR, 2019-09-19
August, 2016 FDA 483 Response Par Sterile Products LLC - Form 483R, 2016-09-15
June, 2017 FDA 483 Diversified Pharmacy Inc dba University Compounding Pharmacy - Form 483, 2017-06-19
September, 2018 EIR Pharmacia & Upjohn Company LLC - EIR, 2018-09-21
September, 2018 FDA 483 Pharmacia & Upjohn Company LLC - Form 483, 2018-09-21
January, 2019 EIR ANDERSONBRECON INC. - EIR, 2019-01-10
September, 2019 FDA 483 SpecGx LLC - Form 483, 2019-09-12
September, 2018 EIR Pharmacia & Upjohn Company LLC - EIR, 2018-12-10
May, 2021 FDA 483 Morton Grove Pharmaceuticals, Inc. - Form 483, 2021-05-20
October, 2019 EIR LEXAMED - EIR, 2019-10-10
August, 2019 FDA 483 Nippon Shikizai,inc. - Form 483, 2019-08-06
August, 2018 FDA 483 Hudson Scientific LLC - Form 483, 2018-08-07

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more